Analysis built on national registers, where the cohort is a whole population and follow-up is near-complete. The strengths and the traps both come from data collected for another purpose entirely.
Also called registry-based research, real-world data.
Worked through2
The evidence67
- Risk of first and second primary keratinocyte cancers in relation to treatment of rheumatoid arthritis with JAKi, TNFi, and non-TNFi bDMARDs—a Swedish nationwide study.
- Increased risk of hip and other major osteoporotic fractures within 18 months of lymphoma diagnosis—a national registry study of 36,864 Swedish lymphoma patients.
- Congenital heart defects: familial recurrence patterns in Sweden.
- Utilisation of Healthcare in Children Born to Lymphoma Survivors in Sweden.
- Temporal comorbidity patterns preceding MASLD-related major adverse liver outcomes: a nationwide population-based case–control study in Sweden.
- Risk of hepatic decompensation or HCC is similar in patients with ALD- and MASLD-cirrhosis: A population-based cohort study.